Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Neuren Pharmaceuticals Limited (AU:NEU)

ASX:NEU

Australian Market

NEU

Neuren Pharmaceuticals Limited

Analyst Forecasts

News & Insights

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Neuren Pharmaceuticals Limited (NEU) Stock News & Sentiment

190 Followers

Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Pitt Hopkins Syndrome

Company Announcements

Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Pitt Hopkins Syndrome

3d ago

Neuren Pharmaceuticals Gains Financial Boost from Voucher Sale

Company Announcements

Neuren Pharmaceuticals Gains Financial Boost from Voucher Sale

15d ago

Neuren Pharmaceuticals Secures FDA Type C Meeting for Phelan-McDermid Syndrome Trial

Company Announcements

Neuren Pharmaceuticals Secures FDA Type C Meeting for Phelan-McDermid Syndrome Trial

15d ago

Neuren Pharmaceuticals to Present at 2025 Autism Research Meeting

Company Announcements

Neuren Pharmaceuticals to Present at 2025 Autism Research Meeting

16d ago

Neuren Pharmaceuticals Advances Drug Development and Expands Market Reach

Company Announcements

Neuren Pharmaceuticals Advances Drug Development and Expands Market Reach

1M ago

Neuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference

Company Announcements

Neuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference

1M ago

Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome

Company Announcements

Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome

1M ago

More AU:NEU News >

NEU News on the Web

2025-02-12

Rare opportunities – ASX health stocks tackling unmet medical needs

StockHead

Neutral

2025-02-07

Lunch Wrap: Oil stocks drag down ASX, but KalGold triples after ripper gold find

StockHead

Neutral

2025-02-06

A Look At The Fair Value Of Neuren Pharmaceuticals Limited (ASX:NEU)

Simply Wall St

Neutral

2025-02-03

Health Check: Fisher #038; Paykel Healthcare shares tumble after Trump tariff king-hit

StockHead

Neutral

2025-01-29

Phase III Trials: It#8217;s crunch time for these ASX health stocks

StockHead

Neutral

2025-01-24

Scott Power: Cardiac pacing device developer EBR hits Morgans price target amid #8216;rotation back into healthcare#8217;

StockHead

Neutral

2025-01-22

Neuren Pharmaceuticals Limited's Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Yahoo Finance

Neutral

2025-01-19

Jefferies Sticks to Their Buy Rating for Neuren Pharmaceuticals Limited (NURPF)

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

AU:NEU

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:NEU’s Media Buzz Sentiment?

Currently, no data Available

What is AU:NEU’s weekly average amount of articles?

Currently, no data Available

What is AU:NEU’s News Sentiment?

59% of articles about AU:NEU were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

RCUSArcus Biosciences

SHGSingular Health Group Ltd

HCMHUTCHMED

PENPenumbra

BNTCBenitec Biopharma

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing